AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32093617 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (30 mg)
Number of subjects: 34
Study 32556659 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + nutraceutical agent (test group)
Number of subjects: 66
Study 32556659 — intervention group
Group type: COMPARATOR
Intervention: SRP alone (control group)
Number of subjects: 66
Study 32351995 — intervention group
Group type: EXPERIMENTAL
Intervention: Dingji Fumai Decoction (DFD) combined with metoprolol
Number of subjects: 144
Study 32351995 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol combined with placebo (MET)
Number of subjects: 144
Study 36081470 — intervention group
Group type: EXPERIMENTAL
Intervention: SAS video collage arm
Number of subjects: 10000
Study 36081470 — intervention group
Group type: COMPARATOR
Intervention: Attention placebo control video arm
Number of subjects: 10000
Study 36081470 — intervention group
Group type: COMPARATOR
Intervention: No intervention arm
Number of subjects: 10000
Study 32059691 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-lower limb (LL) plus PNF
Number of subjects: 40
Study 32059691 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-lower limb (LL) and respiration
Number of subjects: 40
Study 32059691 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-upper limb (UL) plus PNF
Number of subjects: 40
Study 32059691 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-upper limb (UL) and respiration
Number of subjects: 40
Study 32059691 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 40
Study 34459089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention (CBT) with compassion-focused therapy methods, delivered in six sessions.
Number of subjects: 22
Study 34459089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention (CBT)
Number of subjects: 22
Study 34020614 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Based Intervention (FBI) involving a multicomponent health-promotion intervention targeting children, families, and CCC, based on the Motivational Interviewing (MI) approach, focusing on dietary habits, physical activity, screen time, sleep duration, and psychological well-being.
Number of subjects: 810
Study 34020614 — intervention group
Group type: COMPARATOR
Intervention: Control group participated in a unique workshop on general awareness of healthy lifestyles for families.
Number of subjects: 810
Study 36203226 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 C-based models
Number of subjects: 136
Study 36203226 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC-based models
Number of subjects: 136
Study 36203226 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 W-based models
Number of subjects: 136
Study 33077017 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline (HYPER) infusion (0.1 ml/kg per min for 2 hours)
Number of subjects: 49
Study 33077017 — intervention group
Group type: COMPARATOR
Intervention: 0.9% isotonic saline (ISO) as control
Number of subjects: 49
Study 35595850 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleguided multidisciplinary intervention
Number of subjects: 58
Study 35595850 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus educational website access (Control)
Number of subjects: 58
Study 33896823 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐142‐3p, miR‐146a‐5p, and miR‐151a‐5p in plasma of EC patients
Number of subjects: 93
Study 33896823 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐miRNA signature
Number of subjects: 93
Study 33896823 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐151a‐5p in plasma exosomes
Number of subjects: 93
Study 33523582 — intervention group
Group type: EXPERIMENTAL
Intervention: PICSI
Number of subjects: 45
Study 33523582 — intervention group
Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 45
Study 35412061 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable ultrasound-guided REBOA
Number of subjects: 11
Study 35412061 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual extracorporeal compression
Number of subjects: 11
Study 33964853 — intervention group
Group type: EXPERIMENTAL
Intervention: Wolfberry (15 g/d)
Number of subjects: 40
Study 33964853 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: CA19-9
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: CEA
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: SLX
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor Size
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: Mural Nodule Presence
Number of subjects: 283
Study 32354795 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 283
Study 32354795 — intervention group
Group type: COMPARATOR
Intervention: CA125
Number of subjects: 283
Study 35404830 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-enhanced Behavioral Activation (VR BA)
Number of subjects: 13
Study 35404830 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Activation (BA)
Number of subjects: 13
Study 35404830 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual control
Number of subjects: 13
Study 33450885 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic HN001 (n = 172)
Number of subjects: 348
Study 33450885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 176)
Number of subjects: 348
Study 32862743 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 120
Study 32862743 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 120
Study 32862743 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 34789846 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scores for alcohol use in African Americans (AA)
Number of subjects: 463
Study 34789846 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scores for alcohol use in European Americans (EA)
Number of subjects: 463
Study 36096706 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS risk score group
Number of subjects: 5206
Study 36096706 — intervention group
Group type: COMPARATOR
Intervention: CHA2DS2-VASc risk score group
Number of subjects: 5206
Study 34056740 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate levels (genetic variants underlying urate levels)
Number of subjects: 0
Study 35086677 — intervention group
Group type: EXPERIMENTAL
Intervention: MIKT
Number of subjects: 148
Study 35086677 — intervention group
Group type: COMPARATOR
Intervention: CKT
Number of subjects: 148
Study 34657274 — intervention group
Group type: EXPERIMENTAL
Intervention: AVT02
Number of subjects: 413
Study 34657274 — intervention group
Group type: COMPARATOR
Intervention: Originator adalimumab
Number of subjects: 413
Study 34657274 — intervention group
Group type: EXPERIMENTAL
Intervention: AVT02 and Originator adalimumab
Number of subjects: 413
Study 35193729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/d
Number of subjects: 0
Study 35193729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 0
Study 35193729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 0
Study 35193729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 6 mg/d
Number of subjects: 0
Study 35193729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32402261 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A)
Number of subjects: 151
Study 32402261 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 151
Study 36216004 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet of less than 1500 mg/day
Number of subjects: 0
Study 36216004 — intervention group
Group type: COMPARATOR
Intervention: Usual care according to local guidelines
Number of subjects: 0
Study 34112174 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred transition programme
Number of subjects: 26
Study 34112174 — intervention group
Group type: COMPARATOR
Intervention: Support to parents
Number of subjects: 26
Study 32379657 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter programme with entrainment music
Number of subjects: 36
Study 32379657 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 35680626 — intervention group
Group type: EXPERIMENTAL
Intervention: IAC regimen (idarubicin, cytarabine, and cyclophosphamide)
Number of subjects: 42
Study 35680626 — intervention group
Group type: COMPARATOR
Intervention: Control regimen (selected by doctors)
Number of subjects: 42
Study 35680626 — intervention group
Group type: EXPERIMENTAL
Intervention: IAC regimen
Number of subjects: 42
Study 35680626 — intervention group
Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 42
Study 35680626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation group
Number of subjects: 42
Study 35680626 — intervention group
Group type: COMPARATOR
Intervention: Non-hematopoietic stem cell transplantation group
Number of subjects: 42
Study 33932589 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg, intravenously, Q 12 h) for the first 5 postoperative days
Number of subjects: 134
Study 33932589 — intervention group
Group type: COMPARATOR
Intervention: On-demand opioid analgesics (pethidine or morphine) postoperatively
Number of subjects: 134
Study 35829974 — intervention group
Group type: EXPERIMENTAL
Intervention: Delicate pulsed light (DPL) combined with low-dose oral isotretinoin (10–20 mg/day)
Number of subjects: 36
Study 35829974 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin monotherapy
Number of subjects: 36
Study 33888069 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal cord radiotherapy (VC‐RT)
Number of subjects: 155
Study 33888069 — intervention group
Group type: COMPARATOR
Intervention: Complete laryngeal radiotherapy (CL‐RT)
Number of subjects: 155
Study 35040001 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent‐implemented Early Start Denver Model (P‐ESDM) with Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 63
Study 35040001 — intervention group
Group type: COMPARATOR
Intervention: Parent‐implemented Early Start Denver Model (P‐ESDM) without Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 63
Study 35362185 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive coercion experience among female participants
Number of subjects: 2291
Study 35362185 — intervention group
Group type: EXPERIMENTAL
Intervention: Care seeking for counselling and healthcare among female participants who experienced reproductive coercion
Number of subjects: 2291
Study 35362185 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent use of reproductive coercion among male participants
Number of subjects: 2291
Study 34379891 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV‐NAVA
Number of subjects: 23
Study 34379891 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 23
Study 34379891 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 23
Study 35379633 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pancreaticoduodenectomy (LPD)
Number of subjects: 200
Study 35379633 — intervention group
Group type: COMPARATOR
Intervention: Open pancreaticoduodenectomy (OPD)
Number of subjects: 200
Study 33742786 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM9161 340 mg
Number of subjects: 24
Study 33742786 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM9161 510 mg
Number of subjects: 24
Study 33742786 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM9161 680 mg
Number of subjects: 24
Study 33742786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33742786 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM9161
Number of subjects: 24
Study 32799925 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMROSE intervention
Number of subjects: 30
Study 35034311 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim-cbqv
Number of subjects: 0
Study 35034311 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim
Number of subjects: 0
Study 33567406 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task head rotations on foam condition
Number of subjects: 20
Study 33567406 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task head rotations on firm surface
Number of subjects: 20
Study 33567406 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field flow on firm surface
Number of subjects: 20
Study 33567406 — intervention group
Group type: EXPERIMENTAL
Intervention: Head rotations on foam surface
Number of subjects: 20
Study 33567406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance
Number of subjects: 20
Study 32521553 — intervention group
Group type: EXPERIMENTAL
Intervention: 26-item German IQCODE version (telephone interview)
Number of subjects: 60
Study 32521553 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-item short telephone version of the IQCODE
Number of subjects: 60
Study 35783528 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinjia Xuanbai Chengqi granules (XJXBCQ) combined with conventional treatment (budesonide suspension)
Number of subjects: 330
Study 35783528 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinjia Xuanbai Chengqi granules (XJXBCQ) and budesonide suspension (full dosage)
Number of subjects: 330
Study 35783528 — intervention group
Group type: COMPARATOR
Intervention: Control group (budesonide suspension and placebo)
Number of subjects: 330
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy programme (36 one-hour sessions over 12 weeks, including 45 minutes of face-to-face therapy)
Number of subjects: 259
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care goals
Number of subjects: 259
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Productivity goals
Number of subjects: 259
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure goals
Number of subjects: 259
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Other goals
Number of subjects: 259
Study 32914639 — intervention group
Group type: EXPERIMENTAL
Intervention: Goals achievement based on time post stroke
Number of subjects: 259
Study 35523631 — intervention group
Group type: EXPERIMENTAL
Intervention: Active diagnostic strategy for pulmonary embolism (PE)
Number of subjects: 175
Study 35523631 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 175
Study 32434291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized dexmedetomidine (1 µg/kg in 3‐4 ml of 0.9% saline)
Number of subjects: 120
Study 32434291 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (3‐4 ml)
Number of subjects: 120
Study 32434291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized dexmedetomidine
Number of subjects: 120
Study 32434291 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 120
Study 33210977 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 33210977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35065683 — intervention group
Group type: COMPARATOR
Intervention: High-titre RV3-BB vaccine
Number of subjects: 711
Study 35065683 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-titre RV3-BB vaccine
Number of subjects: 711
Study 35065683 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-titre RV3-BB vaccine
Number of subjects: 711
Study 35065683 — intervention group
Group type: EXPERIMENTAL
Intervention: High-titre RV3-BB vaccine (infant schedule)
Number of subjects: 711
Study 35065683 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall vaccine take
Number of subjects: 711
Study 35065683 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 711
Study 33743009 — intervention group
Group type: EXPERIMENTAL
Intervention: Periareolar dermis release (experimental group)
Number of subjects: 39
Study 33743009 — intervention group
Group type: COMPARATOR
Intervention: Control group (no periareolar dermis release)
Number of subjects: 39
Study 33423986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (10 mg/kg in 100 ml isotonic saline)
Number of subjects: 60
Study 33423986 — intervention group
Group type: COMPARATOR
Intervention: Control (100 ml isotonic saline)
Number of subjects: 60
Study 35113416 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-forearm group (120 patients)
Number of subjects: 240
Study 35113416 — intervention group
Group type: COMPARATOR
Intervention: Wrist group (120 patients)
Number of subjects: 240
Study 33979557 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (BUD-FORM)
Number of subjects: 6735
Study 33979557 — intervention group
Group type: COMPARATOR
Intervention: BUD maintenance
Number of subjects: 6735
Study 34346831 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-regulatory progressive resistance exercise (APRE)
Number of subjects: 24
Study 34346831 — intervention group
Group type: COMPARATOR
Intervention: Linear programming resistance exercise (LPRE)
Number of subjects: 24
Study 34346831 — intervention group
Group type: EXPERIMENTAL
Intervention: Both APRE and LPRE
Number of subjects: 24
Study 32115370 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE Steps to Success intervention
Number of subjects: 39
Study 32115370 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations for implementing palliative care
Number of subjects: 39
Study 34520052 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1-based first-line treatment
Number of subjects: 82
Study 33204004 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 44
Study 33204004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 33204004 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (under 30 days)
Number of subjects: 44
Study 33204004 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (over 30 days)
Number of subjects: 44
Study 33843477 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin Block group (TB)
Number of subjects: 30
Study 33843477 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator group (B)
Number of subjects: 30
Study 33843477 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 30
Study 33709771 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Pilates Exercises (CPE), performed two times a week for 8 weeks
Number of subjects: 55
Study 33709771 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study 33348180 — intervention group
Group type: EXPERIMENTAL
Intervention: SCL‐20
Number of subjects: 409
Study 33348180 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ‐9
Number of subjects: 409
Study 35157236 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK3486 0.4 mg/kg
Number of subjects: 267
Study 35157236 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2.0 mg/kg
Number of subjects: 267
Study 33746195 — intervention group
Group type: EXPERIMENTAL
Intervention: Papilocare, a Coriolus versicolor-based vaginal gel
Number of subjects: 91
Study 33746195 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting approach (control)
Number of subjects: 91
Study 32122315 — intervention group
Group type: EXPERIMENTAL
Intervention: NEVERMIND system (smart shirt and mobile application)
Number of subjects: 330
Study 32122315 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 330
Study 32122315 — intervention group
Group type: EXPERIMENTAL
Intervention: NEVERMIND system
Number of subjects: 330
Study 35170523 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified UK diagnostic tool
Number of subjects: 538
Study 35170523 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported medically diagnosed eczema
Number of subjects: 538
Study 35170523 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported use of topical corticosteroids
Number of subjects: 538
Study 35170523 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Oriented Eczema Measure (POEM) scores
Number of subjects: 538
Study 35170523 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORing Atopic Dermatitis (SCORAD) clinical assessment
Number of subjects: 538
Study 34847063 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistrategy behavioral intervention (Click & Crunch)
Number of subjects: 2207
Study 34847063 — intervention group
Group type: COMPARATOR
Intervention: Control (usual online ordering only)
Number of subjects: 2207
Study 35551628 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange (TPE)
Number of subjects: 100
Study 35551628 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 100
Study 35551628 — intervention group
Group type: EXPERIMENTAL
Intervention: TPE
Number of subjects: 100
Study 35551628 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 100
Study 32353206 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual training (IT)
Number of subjects: 90
Study 32353206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training (GT)
Number of subjects: 90
Study 32353206 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual training progressing to group training (IPGT)
Number of subjects: 90
Study 32353206 — intervention group
Group type: COMPARATOR
Intervention: Control group (GT only)
Number of subjects: 90
Study 35710091 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf muscle exercise training (ETC) in addition to compression therapy (CT)
Number of subjects: 32
Study 35710091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) in addition to compression therapy (CT)
Number of subjects: 32
Study 35710091 — intervention group
Group type: COMPARATOR
Intervention: Compression therapy (CT) alone
Number of subjects: 32
Study 33957371 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase 1.5 mg
Number of subjects: 24
Study 33957371 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase 3 mg
Number of subjects: 24